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Abstract
The mdx mouse is an animal model for Duchenne muscular dystrophy (DMD), which is caused by the absence of
dystrophin. Mdx limb muscles substantially compensate for the lack of dystrophin while the diaphragm is affected like DMD
skeletal muscles. To understand better the complex cascade of molecular events leading to muscle degeneration and
compensatory processes in mdx muscles, we analyzed alterations of gene expression in mdx hindlimb and diaphragm muscles
as compared to their normal counterparts. The strategy was based on suppression subtractive hybridization followed by
reverse Northern quantitative hybridization. Four subtracted/normalized libraries, containing cDNA clones up- or
downregulated in mdx hindlimb muscles or diaphragm, were constructed and a total of 1536 cDNA clones were analyzed.
Ninety-three cDNAs were found to be differentially expressed in mdx hindlimb muscles and/or diaphragm. They
corresponded to 54 known genes and 39 novel cDNAs. The potential role of the known genes is discussed in the context of
the mdx phenotype. ß 2000 Elsevier Science B.V. All rights reserved.
Keywords: Mdx mouse; Muscle regeneration; Di¡erential gene expression; Suppression subtractive hybridization; Reverse Northern
1. Introduction
A mouse su¡ering from murine X-linked muscular
dystrophy (mdx) [1] is an animal model for Du-
chenne muscular dystrophy (DMD), a disease char-
acterized by the absence of dystrophin [2,3]. In spite
of a homologous genetic defect, there is a marked
di¡erence between the dystrophic phenotype in limb
muscles of DMD patients and those of mdx mice,
since limb muscles of mdx mice successfully compen-
sate for the absence of dystrophin following several
degeneration and regeneration cycles between 3 and
4 weeks of age. In contrast to limb muscles, the mdx
mouse diaphragm exhibits a characteristic pattern of
degeneration, ¢brosis and severe functional de¢-
ciency, similar to that of DMD skeletal muscles [4],
which makes it a good model for Duchenne muscular
dystrophy. Although much has been done to eluci-
date the structure and function of dystrophin and the
dystrophin associated complex, little is known about
a cascade of molecular events triggered by the ab-
sence of dystrophin and leading to muscle degener-
ation. It would also be useful to understand the
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mechanism of compensation for the absence of dys-
trophin in mdx limb muscles and what di¡erentiates
these muscles from mdx diaphragm. This informa-
tion is of great interest from a scienti¢c point of
view, and may also provide some ideas for possible
therapeutic intervention. It would thus be especially
interesting to determine how dystrophin de¢ciency is
described in terms of gene expression.
We present here data on the large-scale analysis of
gene expression in mdx mouse muscles obtained us-
ing a strategy based on suppression subtractive hy-
bridization (SSH) [5,6] and reverse Northern quanti-
tative hybridization. SSH allows construction of
normalized/subtracted libraries which contain equal-
ized amounts of highly, moderately and low ex-
pressed cDNAs and are enriched in di¡erentially ex-
pressed sequences. Such libraries, containing clones
di¡erentially expressed in mdx hindlimb muscles and
diaphragm, were prepared and organized on low
density colony ¢lters, which were then screened using
subtracted probes that allowed easy identi¢cation of
potentially di¡erential clones. These clones were ar-
rayed on membranes and their expression was ana-
lyzed using quantitative hybridization. This proce-
dure enabled us to identify 93 genes di¡erentially
expressed in the mdx hindlimb muscles and dia-
phragm, including 54 known and 39 unknown genes
that fall into six functional categories. Comparative
analysis of the expression levels of these genes in
normal and mdx hindlimb muscles and diaphragm
resulted in identi¢cation of genes potentially respon-
sible for the characteristic features of dystrophin de-
¢cient muscles.
2. Materials and methods
2.1. Isolation of total RNA and poly(A)+ RNA
puri¢cation
Total mouse RNAs were isolated from 3 month
old male C57BL/10mdx (mdx) and C57BL/10ScSn
(BL10) control mouse hindlimb muscles (L) and dia-
phragm (D), as previously described [7], using pools
of tissue from at least six animals to eliminate pos-
sible individual variations in gene expression. Poly-
(A) RNA puri¢cation was carried out using 1 mg of
corresponding total RNA and the mRNA Separator
Kit (Clontech) according to the manufacturer’s pro-
tocol.
2.2. Construction of subtracted libraries using SSH
Subtracted libraries were generated using the PCR-
Select cDNA Subtraction Kit (Clontech) according
to the manufacturer’s protocol with the following
modi¢cations: (i) cDNA synthesis was performed us-
ing 4 Wg of poly(A) RNA; (ii) after incubation with
T4 DNA polymerase, samples were extracted twice
with 100 Wl of a phenol:chloroform:isoamyl alcohol
(25:24:1) mixture followed by one extraction with
chloroform:isoamyl alcohol (24:1) and ethanol pre-
cipitated on ice for 1 h using 4 Wl of 1 mg/ml glyco-
gen as carrier; after centrifugation, pellets were
washed three times with 80% ethanol, dried and re-
suspended in 50 Wl of H2O; (iii) driver cDNAs were
prepared via RsaI digestion for 7 h followed by the
extraction/precipitation procedure described above;
(iv) adapter ligation was carried out at 16‡C for
24 h and ligase was inactivated by heating samples
at 70‡C for 10 min without adding the EDTA/glyco-
gen mix; (v) the ¢rst hybridization was carried out
for 10 h followed by the second hybridization for
16 h; (vi) the primary PCR was performed as fol-
lows: 75‡C for 7 min; 30 cycles at (94‡C for 45 s,
66‡C for 45 s, 72‡C for 2.5 min); followed by ¢nal
extension at 68‡C for 5 min; (vii) the secondary PCR
was carried out under the following cycling condi-
tions: 94‡C for 15 s; 12 cycles at (94‡C for 45 s,
68‡C for 45 s, 72‡C for 2.5 min); followed by ¢nal
extension at 68‡C for 5 min; (viii) to analyze sub-
traction e⁄ciency, the GAPDH speci¢c primers pro-
vided in the kit were used to amplify the correspond-
ing GAPDH fragment; the PCR was performed as
follows: 94‡C for 45 s, 65‡C for 45 s, 68‡C for 2 min.
The following F4 speci¢c primers were used to am-
plify a corresponding fragment of the F4 gene which
was previously shown to be upregulated in mdx
muscles (C.A. Dechesne, unpublished data): F4AL,
5P-GCATGGTGGTTACCTTTGCT-3P ; F4AR, 5P-
CCGTTCTTCCACCACTGATT-3P ; the PCR am-
pli¢cations were carried out under the following con-
ditions: 94‡C for 45 s, 60‡C for 45 s, 68‡C for 2 min.
The PCR products were analyzed by 2% agarose gel
electrophoresis. All PCR ampli¢cations were carried
out using the Advantage cDNA PCR Kit (Clontech).
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2.3. Cloning and low density colony ¢lters
The secondary PCR products were separated by
2% agarose gel electrophoresis and short (200 bp^1
kb) and long (1^5 kb) fragments were eluted from
the gel using dialyzing bags [8] and the QIAquick
PCR Puri¢cation Kit (Qiagen). They were then
cloned separately into the pCRII-TOPO plasmid vec-
tor using the TOPO TA Cloning Kit (Invitrogen).
White bacterial colonies were manually picked into
96 well microtiter plates and grown for 24 h at 37‡C.
Bacterial clones from master plates were manually
printed onto BIOTRANS nylon membrane ¢lters
(ICN Biomedicals, Inc.) placed on top of LB/ampi-
cillin agar using a 96 pin tool and bacteria were
grown overnight at 37‡C.
The ¢lters were denatured on top of 3MM What-
man soaked in 0.5 M NaOH/1.5 M NaCl for 10 min,
neutralized on top of 3MM Whatman soaked in 1 M
Tris-HCl pH 7.5/1.5 M NaCl for 5 min, transferred
to 3MM Whatman soaked in 2USSPE for 10 min
and dried on top of 3MM Whatman for 30 min.
Filters were then treated with proteinase K (ICN
Biomedicals, Inc. ; Cat. No. 193504) for 3 h as pre-
viously described [9], gently manually washed in
5USSPE/0.5% SDS at room temperature using Kim-
wipes to remove remaining debris, rinsed in
2USSPE, dried on top of 3MM Whatman for
30 min followed by UV crosslinking. Filters were
then washed twice for 30 min in 5USSPE/0.5%
SDS at 50‡C and once in 0.1USSPE/0.5% SDS at
50‡C for 30 min with intensive shaking.
2.4. Di¡erential screening of subtracted libraries using
subtracted probes
To prepare subtracted cDNA probes, 60 Wl of each
of the secondary PCR products were puri¢ed using
the QIAquick PCR Puri¢cation Kit (Qiagen) and
eluted in 50 Wl of H2O. 40 Wl were then digested
with RsaI, EaeI and SmaI restriction enzymes to re-
move adapters. After digestion, the samples were pu-
ri¢ed using the QIAquick PCR Puri¢cation Kit (Qia-
gen) as follows: (i) after loading the samples, each
column was washed once with bu¡er PB diluted with
water (5:1); (ii) each column was washed twice with
bu¡er PE; and (iii) the samples were eluted in 50 Wl
of H2O. This step was necessary to remove salts,
proteins and adapters. 2 Wl of each sample was 32P-
labelled using Ready-To-Go DNA Labelling Beads
(3dCTP) (Pharmacia Biotech) and hybridization was
performed overnight at 42‡C in 20 ml of the hybrid-
ization bu¡er (50% formamide/5USSPE/5UDen-
hardt’s solution/0.5% SDS/100 mg/ml salmon sperm
DNA) using 80^100U106 cpm of probe per ¢lter.
The ¢lters were then washed twice for 20 min in
1USSPE/0.2% SDS at room temperature followed
by three 20 min washes in 0.1USSPE/0.2% SDS at
65‡C and exposed to Amersham Hyper¢lm overnight
with intensifying screens.
2.5. Plasmid DNA isolation, sequencing and sequence
analysis
Plasmid DNAs were isolated using the Nucleo-
bond AX20 Kit (Macherey-Nagel) according to the
manufacturer’s protocol. DNA sequencing was car-
ried out by automated means at Genome Express SA
(Grenoble, France). Nucleic acid homology searches
were performed using BLAST software through serv-
ers at the National Center for Biotechnology Infor-
mation (National Institute of Health, Bethesda, MD,
USA).
2.6. Dot blot preparation and reverse Northern
quantitative hybridization
Each plasmid DNA (10 Wl, 200 ng/Wl) or 10 Wl of
PCR ampli¢ed actin cDNA insert was mixed with
2 ml of loading bu¡er (1.5 M NaCl/0.5% bromophe-
nol blue) and 200 Wl of each sample was transferred
onto BIOTRANS nylon membranes (ICN Biomedi-
cals) using the 96 well Bio-Dot Micro¢ltration Ap-
paratus (Bio-Rad). DNA on the membranes was
then denatured by laying on top of 3MM Whatman
soaked in 0.5 M NaOH/1.5 M NaCl for 15 min at
room temperature, neutralized on top of 3MM
Whatman soaked in 1 M Tris-HCl pH 7.5/1.5 M
NaCl for 5 min, membranes were rinsed in 2USSPE
for 5 min, dried on top of 3MM Whatman until
completely dry, and DNA was then UV crosslinked.
cDNAs to be used for preparation of complex
cDNA probes were synthesized using 2 Wg of poly-
(A) RNA and Marathon cDNA Ampli¢cation Kit
(Clontech) following the procedure described above.
The complex cDNA probes were prepared by 32P
BBADIS 61888 25-10-99
A.V. Tkatchenko et al. / Biochimica et Biophysica Acta 1500 (2000) 17^30 19
labeling of 50 ng (two reactions of 25 ng) of each
cDNA using the Random Primers DNA Labeling
System (Gibco BRL) according to the manufactur-
er’s recommendations. Membranes were prehybrid-
ized overnight at 42‡C in the hybridization bu¡er
described above. The prehybridization bu¡er was
then replaced with 20 ml per membrane of hybrid-
ization bu¡er containing 100U106 cpm of the corre-
sponding complex cDNA probe and hybridization
was carried out for 20 h at 42‡C. Probes were care-
fully equilibrated in terms of speci¢c activity and
total radioactivity to certify that exactly the same
amount of labelled cDNA was used for each hybrid-
ized ¢lter. Filters were then washed as described
above and exposed to an imaging plate for 16 h.
The plate was then scanned using the FUJIX BAS
1000 system (Fuji) and images were analyzed and
quanti¢ed using PCBAS 2.09f software. The result-
ing tables containing intensities of all spots, local
backgrounds and surface of each spot were exported
to Excell and further calculations were performed
using an Excell worksheet.
2.7. Northern blot analysis
Aliquots of 20 Wg of mdx or control BL10 mouse
hindlimb muscle or diaphragm total RNA were sep-
arated on 1% formaldehyde/agarose gel and trans-
ferred overnight onto BIOTRANS nylon membranes
(ICN Biomedicals). Filters were prehybridized for 5 h
in the hybridization bu¡er described above, a 32P-
labelled probe was added in the ¢nal concentration
1^2U106 cpm/ml and hybridization was carried out
overnight at 42‡C. Filters were washed as described
above and exposed overnight to an imaging plate or
to the Amersham Hyper¢lm with intensifying screens
for 1^14 days depending on the intensity of the sig-
nal.
Fig. 1. Low density bacterial colony ¢lters hybridization with subtracted probes. The bacterial master plates were used to make two
identical sets of low density colony ¢lters. One set of hindlimb muscle ¢lters was hybridized with the ‘LBL10 vs. Lmdx’ subtracted
probe (Mmp1) and the second set was hybridized with the ‘Lmdx vs. LBL10’ subtracted probe (Mmp2). The low density colony ¢lters
containing diaphragm libraries were hybridized with ‘DBL10 vs. Dmdx’ (Dmp1) and ‘Dmdx vs. DBL10’ (Dmp2) subtracted probes.
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3. Results
3.1. Identi¢cation of cDNAs di¡erentially expressed
in mdx hindlimb and diaphragm muscles
In order to identify genes di¡erentially expressed
in mdx mouse dystrophin de¢cient muscles, we con-
structed four subtracted/normalized libraries using
SSH technology: (i) the ‘LBL10 vs. Lmdx’ (tester
versus driver) library, enriched with sequences that
are downregulated in mdx hindlimb muscles; (ii) the
‘Lmdx vs. LBL10’ library, enriched with sequences
that are upregulated in mdx hindlimb muscles; (iii)
the ‘DBL10 vs. Dmdx’ library, enriched with sequen-
ces downregulated in mdx diaphragm; (iv) the
‘Dmdx vs. DBL10’ library, enriched with sequences
upregulated in mdx diaphragm. Three hundred and
eighty-four clones from each cDNA library were
then organized on four 96 well plates, for a total of
1536 clones arrayed on 16 plates. These master plates
were used to make two identical sets of low density
colony ¢lters. Furthermore, one set of hindlimb
muscle ¢lters was hybridized with the ‘LBL10 vs.
Lmdx’ subtracted probe and a second set was hy-
bridized with the ‘Lmdx vs. LBL10’ subtracted
probe. The same analysis was carried out for low
density colony ¢lters containing diaphragm libraries
using ‘DBL10 vs. Dmdx’ and ‘Dmdx vs. DBL10’
Table 1
Summary of the di¡erential screening using subtracted probes
Hindlimb
libraries
Diaphragm
libraries
Clones analyzed 768 768
Detectable signal 389 563
Di¡erential clones 92 92
Di¡erential cDNAs 51 42
Known genes 29 25
Novel cDNAs 22 17
Redundancy 1.8 2.2
Fig. 2. Reverse Northern quantitative hybridization. 200 ng of each plasmid DNA were spotted on membranes and obtained identical
¢lters were hybridized in parallel with four complex cDNA probes prepared from mRNAs isolated from BL10 hindlimb muscles
(LBL10), mdx hindlimb muscles (Lmdx), BL10 diaphragm (DBL10) and mdx diaphragm (Dmdx).
BBADIS 61888 25-10-99
A.V. Tkatchenko et al. / Biochimica et Biophysica Acta 1500 (2000) 17^30 21
Table 2a
Known genes di¡erentially expressed in the mdx muscles
Name Identity Homology to
known sequences
Reverse Northern hybridization signal
ratio
Lmdx/
LBL10
Dmdx/
DBL10
DBL10/
LBL10
Dmdx/
Lmdx
1. Metabolism and energy production
dif1 lipoprotein lipase 100% (m)a 0.50 0.49 3.4 3.3
dif2 acetyl-CoA synthetase 93% (m) 0.37 1.1 1.3 3.8
dif3 fatty acid synthase 87% (r) 0.30 0.66 1.0 2.3
dif4 stearoyl-CoA desaturase 100% (m) 0.20 0.78 1.1 4.3
dif5 K-methylacyl-CoA racemase 99% (m) 0.41 1.4 2.3 7.6
dif6 glucose transporter 4 (GLUT4) 98% (m) 0.87 0.57 1.7 1.1
dif7 enolase L subunit (muscle speci¢c) 100% (m) 1.0 0.87 0.55 0.47
dif8 phosphoenolpyruvate carboxykinase 100% (m) 0.33 1.2 3.5 13
dif9 sarcomeric mitochondrial creatine kinase 94% (r) 0.51 0.65 3.6 4.6
dif10 ATP synthase Q subunit 85% (h) 0.69 1.1 1.7 2.7
dif11 adenine nucleotide translocase 1 (Ant1) 99% (m) 1.2 0.82 2.1 1.4
dif12 mitochondrial import inner membrane
translocase TIM17
98% (m) 1.4 0.91 2.1 1.4
dif13 S-adenosylmethionine decarboxylase 100% (m) 0.44 0.71 0.11 0.17
2. Growth and di¡erentiation
dif14 H19 100% (m) 3.8 1.9 3.9 2.0
dif15 insulin-like growth factor 2 (Igf2) 95% (m) 5.4 12 1.0 2.2
dif16 GDF8 (myostatin) 100% (m) 0.81 0.81 1.2 1.2
dif17 phosphatidylinositol 3-kinase catalytic subunit
p110 N
100% (m) 1.4 1.0 2.0 1.4
dif18 NF-UB 100% (m) 1.4 1.9 1.6 2.2
dif19 TRAF family member associated NF-UB
activator (TANK)
100% (m) 1.4 1.4 2.5 2.6
dif20 prostaglandin F2K receptor regulatory protein 89% (r) 2.5 1.5 3.8 2.3
dif21 protein arginine N-methyltransferase 85% (h) nsb ns ns ns
3. Calcium homeostasis and protein degradation
dif22 ryanodine receptor type 1 98% (m) 0.36 1.3 0.21 0.73
dif23 sarcolipin 76% (h) 4.5 1.2 15 4.1
dif24 ubiquitin 97% (m) 0.50 0.99 0.66 1.3
dif25 serine protease (Igf regulated) 84% (h) 0.88 1.2 1.4 2.0
4. Cellular organization and biogenesis
dif26 titin Mex1 81% (h) 0.35 1.1 0.20 0.62
dif27 troponin I (slow ¢ber isoform) 93% (r) 4.0 2.0 4.2 2.1
dif28 myosin light chain 2 100% (m) 1.5 1.3 0.50 0.45
dif29 atrial/fetal myosin alkali light chain 99% (m) 3.6 11 0.81 2.5
dif30 K-tubulin 98% (m) 2.4 2.1 1.6 1.4
dif31 Son of Sevenless 2 (SoS2) 90% (m) 0.56 1.1 0.99 1.9
dif32 Rac1 66% (d) 0.77 0.81 4.4 4.6
5. Extracellular matrix, in£ammation and macrophage activation
dif33 collagen type I K2 99% (m) 2.3 3.3 0.84 1.2
dif34 collagen type III K1 88% (h) 4.3 3.0 1.8 1.3
dif35 collagen type V K2 81% (h) 1.4 1.7 1.3 1.6
dif36 uteroglobin 95% (m) ns 0.17 11 ns
dif37 lysozyme M 100% (m) 8.3 3.1 3.9 1.5
dif38 lysozyme P 92% (m) 8.3 3.0 3.8 1.4
dif39 Mpg-1 100% (m) 4.3 3.3 2.0 1.6
dif40 ferritin light chain 99% (m) 2.4 1.6 3.9 2.6
dif41 SpK 99% (m) 0.95 1.8 2.3 4.3
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subtracted probes (Fig. 1). Details of di¡erential
screening using subtracted probes are summarized
in Table 1. Detectable hybridization signals were
obtained for 389 hindlimb muscle clones out of
768 clones analyzed (50.7%) and for 563 diaphragm
clones out of 768 analyzed (73.3%). The 184 clones
(92 from hindlimb libraries and 92 from diaphragm
libraries) gave clear hybridization signals with one of
the probes and did not give any detectable signal
with the probe subtracted in the opposite direction.
Sequence analysis of these clones revealed that they
corresponded to 93 di¡erent cDNAs. A total of
54 cDNAs were identical or highly homologous to
already known sequences (Table 2a), whereas 39 did
not match any known sequences available in public
databases (Table 2b).
3.2. Reverse Northern quantitative analysis
Expression levels of the selected 93 cDNAs poten-
tially di¡erentially expressed in mdx hindlimb
muscles and/or diaphragm were estimated by reverse
Northern analysis. The corresponding 93 plasmid
DNAs were spotted on ¢lters and obtained identical
membranes were hybridized with complex cDNA
probes prepared from hindlimb muscles and dia-
phragm of the BL10 or mdx mice (Fig. 2). Spot-to-
spot variation in the intensity of the hybridization
signal observed for the same cDNA in the multiple
hybridization experiments with complex cDNA
probes was 1.13 þ 0.13 fold (mean þ S.D., n = 12).
Only di¡erences of more than or equal to 1.5-fold
were therefore considered reliable, and all clones
with di¡erences of less than 1.5-fold were considered
as not signi¢cantly di¡erential. Of the 93 cDNAs
analyzed (Table 2a,b), 45 were di¡erentially ex-
pressed in mdx hindlimb muscles and the expression
level of 43 mRNAs was changed in mdx diaphragm
compared to BL10 controls. Of the 45 genes which
showed di¡erential expression in mdx hindlimb
muscles, 25 were more expressed and 20 were less
expressed in mdx muscles. Of the 43 mRNAs whose
expression level was changed in mdx diaphragm, 33
were upregulated and 10 were downregulated in mdx
muscles. The expression level of 56 mRNAs was
changed in BL10 diaphragm versus BL10 hindlimb
muscles and 56 genes showed di¡erential expression
in mdx diaphragm as compared to mdx hindlimb
muscles. Of the 56 genes di¡erentially expressed in
BL10 diaphragm versus BL10 hindlimb muscles,
Table 2a
Known genes di¡erentially expressed in the mdx muscles
Name Identity Homology to
known sequences
Reverse Northern hybridization signal
ratio
Lmdx/
LBL10
Dmdx/
DBL10
DBL10/
LBL10
Dmdx/
Lmdx
6. Unclassi¢ed genes
dif42 arsenite resistance protein (ars2) 93% (hm) 1.1 1.7 1.3 2.0
dif43 selenoprotein P 100% (m) 3.1 1.8 6.3 3.6
dif44 RBM3 85% (h) 3.2 2.1 1.5 0.96
dif45 nmb 77% (h) 7.3 5.3 1.2 0.87
dif46 osteoblast speci¢c factor 2 (OSF-2) 100% (m) 3.0 4.3 1.8 2.7
dif47 H2-Mb (MHC antigen) 98% (m) 3.3 1.4 1.9 0.79
dif48 CRP-ductin-K 100% (m) 1.2 0.50 4.5 1.9
dif49 penta zinc ¢nger protein (Pzf) 99% (m) 0.83 1.0 0.93 1.2
dif50 trg 93% (r) 0.40 1.1 1.4 3.7
dif51 aquaporin-1 (AQP1) 99% (m) 0.77 0.51 1.4 0.91
dif52 furosemide sensitive K-Cl cotransporter 82% (r) 0.96 1.1 1.4 1.6
dif53 K-fetoprotein 99% (m) 0.57 2.3 230 929
dif54 apolipoprotein A-I 100% (m) 1.3 1.6 125 148
Di¡erences bigger than or equal to 1.5-fold are shown in bold.
ad: Drosophila ; h, human; hm, hamster; m, mouse; r, rat.
bns, no hybridization signal detected.
BBADIS 61888 25-10-99
A.V. Tkatchenko et al. / Biochimica et Biophysica Acta 1500 (2000) 17^30 23
45 were more expressed and 11 were less expressed in
diaphragm. The 56 mRNAs with expression level
changed in mdx diaphragm versus mdx hindlimb
muscles included 50 mRNAs that were upregulated
and six downregulated in diaphragm.
3.3. Northern blot analysis of di¡erentially expressed
mRNAs
To assess the reliability of data obtained using
reverse Northern quantitative hybridization, eight
clones were analyzed by Northern blot using 18S
rRNA as a standard. We chose clones corresponding
to mRNAs with various levels of expression and var-
ious mdx versus BL10 di¡erences. In all of these
cases, we obtained results which were virtually iden-
tical to the data produced by reverse Northern (Fig.
3).
4. Discussion
Postnatal mdx skeletal muscles undergo acute de-
generation in 14^21 day old mice immediately fol-
lowed by massive regeneration which seems to be
essentially complete by the age of 3 months. In the
mdx diaphragm, unlike skeletal muscles, a short pe-
riod of relative compensation is followed by the ter-
minal degeneration and ¢brosis which leads to a se-
vere damage of the muscle [4]. In order to unravel
the processes induced by the lack of dystrophin as
well as to get insight into compensatory mechanisms
in the mdx skeletal muscles and molecular events
Fig. 3. Northern blot analysis of mRNAs di¡erentially ex-
pressed in mdx muscles. Total RNAs isolated from BL10 hind-
limb muscles (LBL10), mdx hindlimb muscles (Lmdx), BL10
diaphragm (DBL10) and mdx diaphragm (Dmdx) were electro-
phoresed, blotted and hybridized with dif14, dif15, dif23, dif26,
dif28, dif45, dif70 and dif79 probes (see Table 2a). 18S rRNA
was used as a standard.
Fig. 4. Energy metabolism alterations in mdx muscles. Gray
boxes identify genes whose expression is changed in mdx
muscles. Numbers correspond to fold up- or downregulation of
corresponding mRNAs in mdx hindlimb muscles (M) and dia-
phragm (D). ACOASYN, acetyl CoA synthetase; FAS, fatty
acid synthase; LPL, lipoprotein lipase; PEPCK, phosphoenol-
pyruvate carboxykinase; SCD, stearoyl CoA desaturase;
SMCK, sarcomeric mitochondrial creatine kinase.
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which precede the onset of degeneration in the mdx
diaphragm, we analyzed alterations of gene expres-
sion in diaphragm and hindlimb muscles of 3 month
old mdx mice using a strategy based on SSH and
quantitative hybridization. Expression of 93 genes,
including 39 novel genes, was found to be modi¢ed
in mdx hindlimb muscles and/or diaphragm after
analysis of the 1536 cDNA clones from four normal-
ized/subtracted libraries. The 54 cDNAs which were
identical or highly homologous to already known
sequences were considered to be known gene sequen-
ces and classi¢ed into six functional categories on the
basis of previously known functions of the corre-
sponding genes (Table 2a).
Table 2b
Novel cDNAs di¡erentially expressed in the mdx muscles
Name Reverse Northern hybridization signal ratio
Lmdx/LBL10 Dmdx/DBL10 DBL10/LBL10 Dmdx/Lmdx
dif55 1.7 1.3 1.7 1.4
dif56 0.73 0.44 3.4 2.1
dif57 0.78 0.82 0.97 1.0
dif58 1.1 1.1 2.0 1.9
dif59 0.65 1.1 0.54 0.90
dif60 1.3 4.9 0.39 1.4
dif61 0.80 1.9 1.6 3.9
dif62 0.64 1.5 0.43 1.0
dif63 0.38 1.1 0.98 2.8
dif64 0.54 1.4 0.77 2.1
dif65 0.83 1.4 0.85 1.4
dif66 0.88 1.3 0.85 1.3
dif67 0.86 0.95 0.55 0.61
dif68 1.7 1.2 2.5 1.8
dif69 1.3 1.0 2.1 1.7
dif70 4.0 1.8 3.9 1.8
dif71 nsa ns ns ns
dif72 1.2 1.5 1.2 1.7
dif73 1.8 1.4 1.6 1.2
dif74 0.83 1.5 1.6 2.9
dif75 1.0 1.3 0.74 0.97
dif76 2.9 3.8 1.6 2.2
dif77 0.78 0.94 1.1 1.4
dif78 0.17 1.5 0.63 5.7
dif79 1.5 0.95 3.1 2.0
dif80 0.99 0.41 1.1 0.44
dif81 1.0 0.67 2.2 1.4
dif82 1.2 1.6 1.5 1.9
dif83 1.4 2.0 1.6 2.3
dif84 1.2 1.1 0.87 0.85
dif85 ns ns ns ns
dif86 1.1 1.6 1.1 1.6
dif87 ns ns ns ns
dif88 0.81 0.99 1.1 1.3
dif89 0.55 0.98 1.3 2.4
dif90 0.70 1.2 1.4 2.4
dif91 ns ns ns ns
dif92 ns ns ns ns
dif93 ns ns ns ns
Di¡erences bigger than or equal to 1.5-fold are shown in bold.
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4.1. Metabolism and energy production
The energy metabolism was shown to be reduced
in mdx skeletal muscle ¢bers, mostly due to de-
creased oxidative utilization of glucose and free fatty
acids [10]. In agreement with this observation, the
expression level of several genes encoding key en-
zymes of lipid and carbohydrate metabolism were
found here to be reduced in mdx hindlimb muscles
and diaphragm. Major alterations were found in L-
oxidation and de novo synthesis of fatty acids, with a
greater impact on this part of metabolism in mdx
hindlimb muscles as compared to diaphragm (Fig.
4). Downregulation of S-adenosylmethionine decar-
boxylase (AdoMetDC) mRNA expression in the mdx
hindlimb muscles would further contribute to the
reduced energy metabolism in this tissue as inhibition
or downregulation of AdoMetDC leads to an in-
creased putrescine intracellular concentration and
to a decline in spermidine and spermine levels. This
change in relative polyamine concentrations causes
disturbances in mitochondrial metabolism since sper-
mine was shown to be an important regulator of
mitochondrial transport processes [11].
4.2. Growth and di¡erentiation
The tightly linked imprinted mouse genes H19 and
Igf2 are expressed in many tissues of endodermal and
mesodermal origin during embryogenesis [12,13] but
are sharply downregulated in most of these tissues
shortly after birth. Although the function of the
H19 gene is currently completely unknown, its ex-
pression was shown to be closely associated with
the beginning of the di¡erentiation process in muscle
cells [14], and it is widely recognized as an oncofetal
marker [12]. The induction of H19 gene expression in
mdx muscles would therefore logically be connected
to active muscle cell proliferation and di¡erentiation
in these tissues. Igf2, the major growth factor for
many tissues during embryonic development, was
shown to be directly implicated in overgrowth of
several organs in patients with Beckwith-Wiedemann
syndrome [15,16]. Hence, muscle hypertrophy, which
is a characteristic feature of the mdx phenotype, can
be explained by the here described induction of Igf2
gene expression in mdx muscles. The expression of
mRNA for the NF-UB transcription factor [17] is
increased in mdx hindlimb muscles and diaphragm.
NF-UB was shown to be involved in many aspects of
cell growth, proliferation and di¡erentiation [17,18],
including fusion of myoblasts into myotubes
through activation of the expression of myoblast
nitric oxide synthase (NOS), which seems to play
an important role in this process [19]. In addition,
upregulation of the prostaglandin F2K (PGF2K) re-
ceptor regulatory protein, a negative regulator of
the PGF2K receptor [20,21], in mdx hindlimb muscles
and diaphragm may in£uence signaling in a¡ected
cells since PGF2K was shown to be involved in
the regulation of cell proliferation [22] and stimulate
hypertrophic growth of cultured myocytes [23]
through the calcium and PI 3-kinase dependent path-
ways.
4.3. Calcium homeostasis and protein degradation
Although there are some contradictory reports, in-
creasing evidence suggests that the free intracellular
calcium level is elevated in mdx myo¢bers [24^31].
One of the components of the mechanism responsible
for the increased level of intracellular calcium was
shown to be the abnormal activity of calcium leak
channels resulting in increased calcium in£ux [32].
The reduced calcium uptake by the sarcoplasmic re-
ticulum would also increase the level of free intra-
cellular calcium. The small hydrophobic protein sar-
colipin tightly associated with the fast-twitch skeletal
muscle sarcoplasmic reticulum Ca2ATPase (SER-
CA1) [33] could be involved in the regulation of cal-
cium homeostasis in dystrophin de¢cient muscle cells
since it was shown to be a negative regulator of
SERCA1 [34,35]. The upregulation of sarcolipin
gene expression in mdx hindlimb muscles may there-
fore lead to the diminished calcium accumulation by
sarcoplasmic reticulum and promote the elevation of
calcium level in the cytoplasm. The observed down-
regulation of ryanodine receptor type 1 (RyR1) gene
expression in mdx hindlimb muscles will cause fur-
ther disruption of calcium homeostasis. The elevated
free cytoplasmic calcium was found to be implicated
in activation of apoptosis and increased protein deg-
radation [36]. An increase in calcium dependent pro-
tease (calpain) concentrations was indeed found in
mdx limb muscles but the overall level of calcium
dependent proteolytic activities was lower in compar-
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ison to control mouse muscles [37]. This suppression
of calcium mediated proteolysis in mdx limb muscles
may be partly explained by the downregulation of
ubiquitin mRNA expression in mdx hindlimb
muscles described here since ubiquitin is the key
component of the calcium regulated protein degrada-
tion system [38].
4.4. Cellular organization and biogenesis
Several genes encoding components of the muscle
sarcomere (myosin light chain 2, fetal myosin alkali
light chain and troponin I) are overexpressed in mdx
hindlimb muscles and diaphragm. The increased ex-
pression level of these mRNAs is probably a re£ec-
tion of the proliferation/di¡erentiation occurring in
mdx muscles since increased production of these pro-
teins is known to be associated with the early stages
of muscle cell di¡erentiation. K-Tubulin (2-fold up-
regulation in mdx hindlimb muscles and diaphragm)
is a constitutive component of microtubules which,
along with actin and intermediate ¢laments, is the
main component of the cellular cytoskeleton and mi-
totic spindle of proliferating cells [39]. Overproduc-
tion of K-tubulin in mdx muscles is therefore likely
associated with an increased number of mitoses in
mdx tissues. Tubulin was shown to bind Rac1 [40],
which has a key role in the regulation of actin ¢la-
ment assembly and cytoskeletal organization [41,42].
Rac1 is coupled to the Ras signaling pathway
through the Ras-speci¢c exchange factor Son of Sev-
enless 2 (SoS2) [43], which is downregulated in mdx
hindlimb muscles.
An interesting phenomenon is the di¡erential ex-
pression of the ¢rst exon encoding M-line titin
(Mex1), which is downregulated in mdx hindlimb
muscles. This region of the M-line titin is known to
be actively phosphorylated during myoblast di¡eren-
tiation and to play an important role in sarcomere
assembly [44]. A switch from the normal titin iso-
form to the isoform lacking this portion may lead
to signi¢cant changes in sarcomere structure.
Coupled with destabilization of the cytoskeleton as
a possible outcome of the downregulation of Rac1
and SoS2 mRNA expression described above, it may
in£uence the overall stability of muscle cells, includ-
ing resistance to stretch which is known to be re-
duced in mdx myo¢bers, and explain muscle cell
shape abnormalities, a characteristic feature of dys-
trophin de¢cient muscles.
4.5. Extracellular matrix, in£ammation and
macrophage activation
The well known proliferation of connective tissue
in dystrophin de¢cient muscles was shown to be as-
sociated with collagen accumulation [45,46]. Here,
we show that all three major types of collagen spe-
ci¢cally expressed in connective tissue (collagen I, III
and V) [47] are upregulated in mdx muscles. The
observed induction of collagen genes may be attrib-
uted to the high level of Igf2 expression in the mdx
hindlimb muscles and diaphragm, since Igf2 is
known to be a strong inducer of collagen I and III
gene expression [48]. Another factor that may facili-
tate ¢brosis in mdx diaphragm is downregulation of
uteroglobin gene expression in this tissue. Uteroglo-
bin is a secretory protein that is produced mostly by
epithelial cells in many mammalian organs [49]. A
clear hybridization signal was observed in control
mouse diaphragm with 5.9-fold downregulation in
mdx diaphragm. No uteroglobin expression was de-
tected in hindlimb muscles. A physiological role(s) of
uteroglobin has not been clearly established. How-
ever, it was shown to inhibit immune and in£amma-
tory processes [49]. In addition, uteroglobin is able to
prevent self-aggregation of ¢bronectin [50] and pos-
sibly other extracellular matrix proteins. The strong
repression of uteroglobin mRNA expression in the
mdx diaphragm described here may therefore lead
to an increase in in£ammatory activities and deposi-
tion of collagen, thus contributing to the overall deg-
radation and ¢brosis observed in this tissue.
Sites of muscle necrosis attract numerous macro-
phages, which is another characteristic feature of
dystrophin de¢cient muscles. Induction of macro-
phage speci¢c mRNAs for lysozymes and Mpg-1 as
well as for ferritin light chain described here is most
likely associated with macrophage maturation and
activation since the expression of these mRNAs
was shown to be gradually increased during macro-
phage di¡erentiation [51^53]. SpK (upregulated in
mdx diaphragm), a recently identi¢ed member of
the SRCR (scavenger receptor cysteine rich) protein
family whose expression is restricted to lymphoid
tissues, is also likely involved in macrophage activa-
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tion since it speci¢cally binds peripheral blood
mononuclear cells [54].
4.6. Unclassi¢ed genes
Several known genes that did not fall into any of
the functional categories described above were shown
here to be di¡erentially expressed in mdx muscles.
They include genes encoding MHC antigen H2-Mb,
selenoprotein P, arsenite resistance protein 2 (ars2)
and the highly conserved RNA binding protein
RBM3 which are overexpressed in mdx muscles
and shown to be involved in the stress response
[55^57]. Two transmembrane proteins with unknown
function, i.e. nmb [58] and osteoblast speci¢c factor 2
(OSF-2) [59], are strongly upregulated in mdx
muscles. The nmb is shown to be overexpressed in
low metastatic tumor cell lines [58], while OSF-2 is
downregulated in the embryonic rhabdomyosarcoma
cell line RD [60]. CRP-ductin K, a member of the
SRCR protein family [61], is 2-fold downregulated
in mdx diaphragm. The expression of mRNA for
the recently identi¢ed gene trg [62] is downregulated
in mdx hindlimb muscles. Aquaporin 1 (AQP1) (re-
pressed in mdx hindlimb muscles and diaphragm) is
expressed in many tissues, including nonfenestrated
endothelium of striated muscles, and is responsible
for water homeostasis in these tissues [63]. The gene
encoding K-fetoprotein, an oncofetal protein highly
expressed in many tissues during embryogenesis [64],
is downregulated in mdx hindlimb muscles and up-
regulated in mdx diaphragm. Finally, apolipoprotein
A-I, which is overexpressed in the dystrophic chicken
skeletal muscles [65] and di¡erentiating myotubes
[66], is upregulated in both mdx hindlimb muscles
and diaphragm.
4.7. Di¡erences between hindlimb muscles and
diaphragm
The phenotypes displayed by the mdx hindlimb
muscles and diaphragm are di¡erent. The mdx limb
muscles are able to compensate for the lack of dys-
trophin while the diaphragm slips into the degener-
ation process similar to DMD skeletal muscles. To
get insight into possible mechanisms underlying this
di¡erence, we have also analyzed alterations in gene
expression observed between hindlimb muscles and
diaphragm. Of the 56 genes di¡erentially expressed
in BL10 diaphragm versus BL10 hindlimb muscles,
34 showed similar changes in mdx diaphragm versus
mdx hindlimb muscles. However, there was a group
of genes, including genes encoding enzymes involved
in energy metabolism, cell proliferation and di¡eren-
tiation, calcium homeostasis and a number of un-
known genes, whose expression was clearly di¡erent
in mdx diaphragm compared to BL10 diaphragm
and/or mdx hindlimb muscles (Table 2a,b), indicat-
ing that these aspects of muscle function may be
impaired in mdx diaphragm.
5. Conclusions
In contrast to other techniques, the strategy we
have used here to isolate and characterize genes dif-
ferentially expressed in mdx muscles allows rapid ef-
¢cient isolation and characterization of di¡erentially
expressed genes. Hybridization of low density bacte-
rial colony ¢lters with subtracted probes provides a
very e⁄cient way to identify potentially di¡erential
clones. The di¡erential expression can then be con-
¢rmed and further analyzed using reverse Northern
quantitative analysis.
The di¡erences between mdx and BL10 muscles
presented here, as well as many alterations in gene
expression observed between mdx diaphragm and
hindlimb muscles, provide new insights into molecu-
lar mechanism underlying dystrophin de¢ciency and
may explain the di¡erent impact of the absence of
dystrophin on limb muscles and diaphragm of mdx
mice. However, it should be noted that changes in
gene expression do not necessarily re£ect changes in
corresponding proteins, just as changes in proteins
may not be re£ected at the mRNA level. For in-
stance, dystrophin associated proteins, which are
known to be greatly reduced in the mdx skeletal
muscles [67^69], were not identi¢ed here since the
expression level of the corresponding genes is un-
changed in mdx tissues. The complexity of muscle
tissue should also be taken into account. Muscle tis-
sue, in addition to muscle cells, also includes satellite
cells, connective tissue cells, nerves, vascular cells and
macrophages. Therefore, further studies of the pro-
teins encoded by the genes di¡erentially expressed in
mdx muscles, conducted at the single cell level,
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should provide additional information on the possi-
ble pathophysiological mechanism underlying degen-
eration and regeneration processes in mdx muscles.
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